Core Viewpoint - ST Jinfeng's stock price closed at 6.15 yuan, up 3.02%, with a rolling PE ratio of 38.23, marking a new low in 24 days, and a total market value of 5.411 billion yuan [1] Company Overview - Hunan Jinfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with key products including various injections and capsules, many of which are exclusive or included in national medical insurance [2] Financial Performance - In the first quarter of 2025, the company reported revenue of 100 million yuan, a year-on-year decrease of 0.46%, and a net loss of approximately 11.90 million yuan, a significant year-on-year decline of 960.04%, with a gross profit margin of 66.62% [3] Market Position - The average PE ratio for the chemical pharmaceutical industry is 56.10, with a median of 33.11, placing ST Jinfeng at the 96th position in the industry [1][3] - The company has a total market value of 5.411 billion yuan, compared to the industry average market value of 14.154 billion yuan [3]
ST景峰收盘上涨3.02%，滚动市盈率38.23倍，总市值54.11亿元
Sou Hu Cai Jing·2025-07-14 08:29